yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q36959425-3FB8D3E5-7FF0-487C-8857-7E6B33550E09
Q36959425-3FB8D3E5-7FF0-487C-8857-7E6B33550E09
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36959425-3FB8D3E5-7FF0-487C-8857-7E6B33550E09
Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study
P2860
Q36959425-3FB8D3E5-7FF0-487C-8857-7E6B33550E09
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36959425-3FB8D3E5-7FF0-487C-8857-7E6B33550E09
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
924adfe31db7844d8ee168e7ff99ed1b0899add4
P2860
Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults.